Drugs / U-13C-glucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05736367 | Nov 2024 → Jun 2026 overdue | breast cancer | Rutgers, The State University of New Jersey | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | U-13C-glucose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05736367 ↗ |
| Route | Intravenous | “U-13C- glucose intravenous” NCT05736367 ↗ |